Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
230.50
+0.75 (0.33%)
At close: Oct 23, 2026, 4:00 PM EDT
230.60
+0.10 (0.04%)
After-hours: Oct 23, 2026, 7:50 PM EDT
Danaher Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 25,608 | 24,568 | 23,875 | 23,890 | 26,643 | 24,802 |
Revenue Growth | 5.52% | 2.90% | -0.06% | -10.33% | 7.42% | 11.30% |
Gross Profit Gross Profit Growth | 15,201 | 14,552 | 14,231 | 14,048 | 16,188 | 15,343 |
Operating Income Operating Income Growth | 5,626 | 5,378 | 5,197 | 5,300 | 7,580 | 7,082 |
Net Income Net Income Growth | 4,331 | 3,614 | 3,899 | 4,743 | 7,103 | 6,269 |
Earnings Per Share EPS Growth | 6.10 | 5.05 | 5.29 | 6.38 | 9.66 | 8.61 |
EPS Growth | 25.42% | -4.54% | -17.09% | -33.97% | 12.18% | 76.33% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Biotechnology Growth | 7,557 | 7,293 | 6,759 | 7,172 | 8,758 | 8,570 |
Life Sciences Life Sciences Growth | 7,566 | 7,334 | 7,329 | 7,141 | 7,036 | 6,388 |
Diagnostics Diagnostics Growth | 10,485 | 9,941 | 9,787 | 9,577 | 10,849 | 9,844 |
Revenue (Total) Revenue (Total) Growth | 25,608 | 24,568 | 23,875 | 23,890 | 26,643 | 24,802 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,682 | 4,615 | 2,078 | 5,864 | 5,995 | 2,586 |
Total Debt Total Debt Growth | 27,782 | 19,696 | 17,146 | 19,536 | 20,616 | 23,272 |
Net Cash (Debt) Net Cash Growth | -22,100 | -15,081 | -15,068 | -13,672 | -14,621 | -20,686 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -31.17 | -21.06 | -20.44 | -18.40 | -19.84 | -28.08 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,859 | 6,416 | 6,688 | 7,164 | 8,519 | 8,358 |
Capital Expenditures CapEx Growth | -1,132 | -1,156 | -1,392 | -1,383 | -1,118 | -1,240 |
Free Cash Flow Free Cash Flow Growth | 5,727 | 5,260 | 5,296 | 5,781 | 7,401 | 7,118 |
Free Cash Flow Growth | 14.15% | -0.68% | -8.39% | -21.89% | 3.98% | 31.40% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 59.36% | 59.23% | 59.61% | 58.80% | 60.76% | 61.86% |
Operating Margin | 21.97% | 21.89% | 21.77% | 22.18% | 28.45% | 28.55% |
Pretax Margin | 18.81% | 17.23% | 19.46% | 21.11% | 26.82% | 26.25% |
Profit Margin | 16.91% | 14.71% | 16.33% | 19.85% | 26.66% | 25.28% |
FCF Margin | 22.36% | 21.41% | 22.18% | 24.20% | 27.78% | 28.70% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.600 | 1.280 | 1.080 | 1.050 | 1.000 | 0.840 |
Dividend Per Share Growth | 23.58% | 18.52% | 2.86% | 5.00% | 19.05% | 16.67% |
Dividend Yield | 0.69% | 0.56% | 0.47% | 0.45% | 0.38% | 0.26% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.76 | 44.74 | 42.52 | 36.04 | 27.20 | 37.50 |
Forward PE | 25.35 | 28.24 | 28.68 | 31.08 | 26.58 | 33.25 |
P/FCF Ratio | 28.32 | 30.74 | 31.31 | 29.57 | 26.11 | 33.03 |
PS Ratio | 6.33 | 6.58 | 6.94 | 7.16 | 7.25 | 9.48 |